Tapewire

Nasdaq · USD

EDSA

Edesa Biotech, Inc.

Export transactions ↓
Tapewire entity
7223
SEC CIK
0001540159
Parsed reports
237

Last 12 months

Inside the activity.

9 purchase rows · 0 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202630
Mar 202660
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
December 20, 2016 Filed Dec 21, 2016 22:02 UTC GrantShare Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001144204-16-140714 · v455478_4.xml · derivative · entry 1

Olson Charles V · CIK 0001663298 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Shares · 2,500 shares

Expires 2023-12-20

F1 · derivative.exercise_date: Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third on December 20, 2017, as to one-third on December 20, 2018 and as to the remaining one-third on December 20, 2019.

Read SEC document
December 20, 2016 Filed Dec 21, 2016 22:03 UTC GrantShare Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001144204-16-140715 · v455479_4.xml · derivative · entry 1

MORSE DANIEL E. · CIK 0001621331 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Shares · 2,500 shares

Expires 2023-12-20

F1 · derivative.exercise_date: Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third immediately, as to one-third on December 20, 2017 and as to the remaining one-third on June 20, 2018.

Read SEC document
December 20, 2016 Filed Dec 21, 2016 22:01 UTC GrantShare Option (Right to Buy) · Derivative 2,500 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001144204-16-140712 · v455477_4.xml · derivative · entry 1

SAMPAT MAYANK D. · CIK 0001620136 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,500

Underlying: Common Shares · 2,500 shares

Expires 2023-12-20

F1 · derivative.exercise_date: Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third immediately, as to one-third on December 20, 2017 and as to the remaining one-third on June 20, 2018.

Read SEC document
December 20, 2016 Filed Dec 21, 2016 22:00 UTC
NIFFENEGGER KATHIChief Financial Officer
GrantShare Option (Right to Buy) · Derivative 10,000 $0.00 Strike: $2.03 $0.00
Disclosure

SEC source: 0001144204-16-140709 · v455475_4.xml · derivative · entry 1

NIFFENEGGER KATHI · CIK 0001620146 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Shares · 10,000 shares

Expires 2023-12-20

F1 · derivative.exercise_date: Option grant under the 2013 Fixed Share Option Plan, which shall vest as to one-third immediately, as to one-third on December 20, 2017 and as to the remaining one-third on June 20, 2018.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.